SPDR S&P Pharmaceuticals ETF
XPH
XPH
79 hedge funds and large institutions have $172M invested in SPDR S&P Pharmaceuticals ETF in 2017 Q3 according to their latest regulatory filings, with 11 funds opening new positions, 21 increasing their positions, 20 reducing their positions, and 11 closing their positions.
Holders
79
Holders Change
-1
Holders Change %
-1.25%
% of All Funds
1.97%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
11
Increased
21
Reduced
20
Closed
11
Calls
–
Puts
$1K
Net Calls
-$1K
Net Calls Change
-$492K
Top Buyers
1 |
TSS
1
Two Sigma Securities
New York
|
$5.61M |
2 |
![]()
2
JPMorgan Chase & Co
New York
|
$4.29M |
3 |
3
Citadel Advisors
Miami,
Florida
|
$1.15M |
4 |
4
Morgan Stanley
New York
|
$27.3M |
5 |
OLA
5
Oliver Luxxe Assets
Gladstone,
New Jersey
|
$964K |